GlassScriptPhysician profile
Anthony M Scott
NPI 1508146051
$6,154.81
in general payments reported to CMS, 2019-2025
27 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $364 · 2021: $761 · 2022: $702 · 2023: $1,659 · 2024: $1,850 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,788 · Entertainment: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,788.48 |
| Entertainment | $187.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $3,337.02 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endomagnetics LTD | $584.69 | 2024 | Magtrace, Magseed |
| Acell, INC. | $284.55 | 2020 | |
| Baxter Healthcare | $283.23 | 2020-2024 | Tisseel, Floseal |
| Avanos Medical | $277.18 | 2019-2022 | |
| Kub Technologies INC. | $187.17 | 2023 | Mozart |
| Hologic Sales and Service, LLC | $139.84 | 2023-2024 | Localizer, Trident Specimen Radiography System, Trunode |
| Davol INC. | $137.85 | 2021-2025 | Arista |
| Depuy Synthes Sales INC. | $131.12 | 2023-2024 | Matrixrib |
| Genentech USA, INC. | $124.16 | 2023 | Lunsumio |
| Allergan, INC. | $98.66 | 2019 | |
| Medtronic, INC. | $85.02 | 2023-2024 | Interstim |
| Intuitive Surgical, INC. | $77.22 | 2019 | |
| Sanofi-Aventis U.S. LLC | $75.25 | 2024 | |
| Molli Surgical (US) INC | $47.40 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Btg International INC. | $40.96 | 2023 | |
| Innovation Technologies INC | $36.33 | 2023-2024 | Irrisept |
| Abbott Laboratories | $31.27 | 2025 | Cardiomems |
| Haemonetics Corporation | $28.20 | 2023 | Teg5000 Hemostasis Analyzer |
| Axonics, INC. | $25.04 | 2023 | Axonics |
| Daiichi Sankyo INC. | $24.65 | 2022 | |
| Merck Sharp & Dohme LLC | $21.79 | 2024 | Lynparza, Keytruda |
| Chiesi USA, INC. | $18.98 | 2020 | |
| Shire North American Group INC | $17.01 | 2019 | |
| Dilon Technologies, INC. | $13.71 | 2024 | Hemoblast Bellows |
| Pfizer INC. | $13.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.